Czempik Piotr, Cieśla Daniel, Knapik Piotr, Krzych Łukasz
Department of Anaesthesiology and Intensive Care, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland.
Department of Science, Education and New Medical Technologies, Silesian Centre for Heart Diseases, Zabrze, Poland.
Adv Clin Exp Med. 2018 Mar;27(3):327-333. doi: 10.17219/acem/65066.
Acute kidney injury (AKI) in critically ill patients has a deleterious impact on the prognosis, especially when renal replacement therapy (RRT) is required. This issue has not yet been investigated in the intensive care setting in Poland.
The aim of the study was to evaluate the short-term outcomes of AKI-RRT subjects, based on a large registry population.
This observational multicenter study covered 100 demographic and clinical variables from the Silesian Registry of ICUs regarding 15,030 adult patients hospitalized between October 2011 and December 2014. The study group comprised 1,234 AKI individuals (8.2%) who required RRT. The primary outcome was ICU mortality. The length of ICU stay (LOS) was considered the secondary outcome. Observed mortality was compared to that predicted by the Acute Physiology and Chronic Health Evaluation II (APACHE II).
The overall mortality of the patients in the registry was 43.9%; it was higher in AKI-RRT subjects than in non-AKI-RRT counterparts (69.4% vs 41.0%; p < 0.01). The median APACHE II score among AKI-RRT subjects was 26 (IQR: 20-32) points. The observed mortality among AKI-RRT patients was significantly higher than predicted by APACHE II, particularly in individuals with lower baseline risk (overall difference: 14.4%). Six patient-related variables independently predicted ICU mortality with moderate accuracy (area under the receiver operating characteristic, AUROC = 0.675; 95% CI 0.65-0.70). The ICU LOS of AKI-RRT subjects was longer than that of the controls (9.8 [IQR: 4.0-19] vs 5.7 [IQR: 2.1-12] days; p < 0.001).
The mortality of critically ill AKI patients requiring RRT was significantly higher than in the overall ICU population. APACHE II scores underestimate mortality, especially in low-risk AKI-RRT subjects, and therefore should not be used in prognostic models in this cohort.
重症患者的急性肾损伤(AKI)对预后有不利影响,尤其是在需要肾脏替代治疗(RRT)时。波兰重症监护环境下尚未对该问题进行研究。
本研究旨在基于大量登记人群评估接受AKI-RRT治疗患者的短期预后。
这项观察性多中心研究涵盖了西里西亚重症监护病房登记处的100个人口统计学和临床变量,涉及2011年10月至2014年12月期间住院的15,030名成年患者。研究组包括1234名需要RRT的AKI患者(8.2%)。主要结局是重症监护病房死亡率。重症监护病房住院时间(LOS)被视为次要结局。将观察到的死亡率与急性生理与慢性健康状况评估II(APACHE II)预测的死亡率进行比较。
登记处患者的总体死亡率为43.9%;AKI-RRT患者的死亡率高于非AKI-RRT患者(69.4%对41.0%;p<0.01)。AKI-RRT患者的APACHE II评分中位数为26分(四分位间距:20 - 32)。AKI-RRT患者观察到的死亡率显著高于APACHE II预测的死亡率,尤其是在基线风险较低的个体中(总体差异:14.4%)。六个与患者相关的变量以中等准确性独立预测重症监护病房死亡率(受试者操作特征曲线下面积,AUROC = 0.675;95%可信区间0.65 - 0.70)。AKI-RRT患者的重症监护病房住院时间长于对照组(9.8[四分位间距:4.0 - 19]天对5.7[四分位间距:2.1 - 12]天;p<0.001)。
需要RRT的重症AKI患者的死亡率显著高于整个重症监护病房人群。APACHE II评分低估了死亡率,尤其是在低风险AKI-RRT患者中,因此不应在该队列的预后模型中使用。